| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $127.4M | — | +29.2% |
| Cost of Revenue | $77.4M | — | +31.5% |
| Gross Profit | $50.1M | — | +25.7% |
| R&D Expense | $24.5M | — | +14.9% |
| SG&A Expense | $28.6M | — | +39.7% |
| Operating Income | -$23.6M | — | -36.9% |
| Pre-tax Income | -$19.6M | — | -26.0% |
| Income Tax | $557K | — | -27.8% |
| Net Income | -$20.1M | — | -23.5% |
| EPS (Basic) | -$0.25 | — | +80.5% |
| EPS (Diluted) | -$0.25 | — | +80.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $348.2M | -6.1% | — |
| Accounts Receivable | $94.9M | +16.4% | — |
| Current Assets | $461.2M | -1.8% | — |
| Total Assets | $723.3M | -1.3% | — |
| Current Liabilities | $90.6M | -3.8% | — |
| Total Liabilities | $101.2M | -4.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$21.2M | — | -278.8% |
| Capital Expenditures | $289K | — | -25.5% |
| Investing Cash Flow | -$2.3M | — | -81.0% |
| Financing Cash Flow | $996K | — | -95.6% |
| Free Cash Flow | -$21.5M | — | -259.1% |
| Stockholders' Equity | $622.1M | -0.9% | +162.5% |